We are currently working to resolve technical issues preventing us from processing applications or payment for membership. Please email Membership on subscriptions@rheumatology.org.uk with any queries.

The National Early Inflammatory Arthritis Audit (NEIAA) second annual report is now live. It presents information on the quality of care for people living with inflammatory arthritis from 8 May 2019 to 7 May 2020.

The key findings for each quality statement are:

  • QS1: 47% of people were referred from their GP within three working days (vs 41% in year 1)

  • QS2: 48% of people saw a rheumatologist within three weeks (vs 38% in year 1)

  • QS3: 64% of people started treatment within six weeks of referral (vs 54% in year 1)

  • QS4: 94% of people were offered timely access to education on self-management (vs 93% in year 1)

  • QS5: 89% of people had a treatment target set and agreed (vs 84% in year 1)

  • QS6: 92% of people were provided with access to rheumatology specialist advice (vs 92% in year 1)

  • QS7: 48% of people were reported to have received an annual review (vs 43% in year 1)

Read the full report

Data collection was non-mandatory from 27 March 2020 due to the COVID-19 pandemic, therefore, data analysed predominantly reflects activity prior to the major impact of COVID-19.